Indeed, deletion of unit “A” (an inferred enhancer) from GBM cells reduced the expression level of SMO relative to mock-treated cells, whereas deletion of unit “D” (an inferred silencer) gained its expression (Fig. 3f and Additional file 2: Fig. S8b-d). The gene discussed is SMO; the disease is glioblastoma.